12:00 AM
Jun 08, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Prepandrix regulatory update

EMEA's CHMP issued a positive opinion to extend the indication for Prepandrix for use in patients aged 61 and...

Read the full 72 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >